Eloxx Pharmaceuticals Inc (ELOX)
0.855
-0.04
(-5.00%)
USD |
OTCM |
May 06, 15:24
Eloxx Pharmaceuticals 1 Year Total Returns (Daily): -85.63% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -85.63% |
May 02, 2024 | -86.33% |
May 01, 2024 | -87.36% |
April 30, 2024 | -87.01% |
April 29, 2024 | -87.70% |
April 26, 2024 | -87.97% |
April 25, 2024 | -88.47% |
April 24, 2024 | -88.07% |
April 23, 2024 | -88.46% |
April 22, 2024 | -88.78% |
April 19, 2024 | -89.15% |
April 18, 2024 | -87.95% |
April 17, 2024 | -86.25% |
April 16, 2024 | -87.31% |
April 15, 2024 | -87.40% |
April 12, 2024 | -89.21% |
April 11, 2024 | -89.90% |
April 10, 2024 | -88.03% |
April 09, 2024 | -81.56% |
April 08, 2024 | -81.56% |
April 05, 2024 | -76.25% |
April 04, 2024 | -67.12% |
April 03, 2024 | -58.24% |
April 02, 2024 | -60.16% |
April 01, 2024 | -59.36% |
Date | Value |
---|---|
March 28, 2024 | -59.51% |
March 27, 2024 | -63.86% |
March 26, 2024 | -69.96% |
March 25, 2024 | -68.20% |
March 22, 2024 | -72.39% |
March 21, 2024 | -71.30% |
March 20, 2024 | -67.72% |
March 19, 2024 | -71.68% |
March 18, 2024 | -68.44% |
March 15, 2024 | -62.26% |
March 14, 2024 | -66.98% |
March 13, 2024 | -65.73% |
March 12, 2024 | -69.62% |
March 11, 2024 | -68.20% |
March 08, 2024 | -72.86% |
March 07, 2024 | -73.93% |
March 06, 2024 | -72.73% |
March 05, 2024 | -71.02% |
March 04, 2024 | -71.70% |
March 01, 2024 | -73.13% |
February 29, 2024 | -73.24% |
February 28, 2024 | -75.07% |
February 27, 2024 | -78.08% |
February 26, 2024 | -74.41% |
February 23, 2024 | -74.58% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-93.60%
Minimum
Dec 28 2022
114.7%
Maximum
Apr 05 2021
-59.65%
Average
-65.30%
Median
Jun 08 2020
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -90.79% |
Palatin Technologies Inc | -3.65% |
iBio Inc | -90.87% |
Theriva Biologics Inc | -37.06% |
Oragenics Inc | -59.32% |